用药错误及其防范PPT课件

  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。
用药错误及其防范
2019/12/30
复旦大学附属华山医院 王大猷
上海 200040 Wangdayou@hotmail.com
可编辑
1
提要
一、引言 二、ME的定义 三、危害 四、分类 五、原因 六、因素 七、防范对策 八、政府干预的建议 九、结语
2019/12/30
可编辑
2
World Health Assembly resolution 54.11,
21 May 2001: WHO Medicines Strategy
… bearing in mind the previous report on the subject, that highlight challenges
related to the international trade agreements, access to essential drugs, drug quality and rational use of medicines, together with the urgent need to improve access to treating priority health problems such as malaria, childhood illnesses, HIV/AIDS and tuberculosis, among others;
REQUESTS Director-General: …
(3) to provide support for implementation of drug monitoring systems in order better to identify developing resistance, adverse reactions and misuse of drugs within health systems, thus promoting rational use of drugs;
2019/12/30
可编辑
3
World Health Assembly resolution,
May 2002: Quality of Care: Patient Safety
… Concerned that the incidence of adverse events is a challenge to quality of care, a
2019/12/30
可编辑
4
马晓伟副部长部长在2005年4月18日卫 生部医院管理年工作会议上的报告
• 努力提高卫生行政部门管理、统筹、 协调医院工作的能力,提高对医院 的指导、检查、评价、管理和监督 能力。
• 严防医疗事故,减少医患纠纷, 保障医疗安全,提高医疗服务的 安全性和有效性。
• 医务人员不仅在主观上、动机上, 还要在客观上、效果上努力维护 病人健康,对病人不产生伤害。
REQUESTS Director-General: …
(1) to develop global norms, standards and guidelines for the definition, measurement and reporting of adverse events..., and to provide support to countries in developing reporting systems, taking preventive action … ;
2019/12/30
来自百度文库
可编辑
7
引言
原因何在?
1、“安危相易,祸福相生”。药物是“双 刃剑”,不仅能治病,也能致病。安全 性本身就是相对的;
2019/12/30
可编辑
5
一、引 言
合理用药的第一要素是安全, WHO、国家卫生部领导又反复 强调医疗安全的重要性,那么 目前医疗机构的用药安全情况 到底怎么了?
2019/12/30
可编辑
6
引言
• 事实是近年来药源性损害事件在我国 不断上升,有的造成医疗纠纷,有的 酿成医疗事故,不但给病人造成损害, 对医疗机构亦直接造成经济损失,甚 而严重影响了医疗机构的声誉。
(2) to promote framing of evidence-based policies, including global standards that will improve patient care, with particular emphasis on such aspects as product safety, safe clinical practice … and safe use of medicinal products and medical devices, and creation of a culture of safety within health care organizations.
significant avoidable cause of human suffering, and high toll in financial loss and opportunity cost to health services;
Noting that significant enhancement of health systems’ performance can be achieved … by preventing adverse events in particular, and improving patient safety and health care quality in general;
(6) to provide support to Member States to set up efficient national regulatory mechanisms for quality assurance that will help ensure compliance with good manufacturing practices, bioavailability and bioequivalence
相关文档
最新文档